Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats

BACKGROUND: Olanzapine is an orexigenic antipsychotic drug associated with serious metabolic adverse effects in humans. Development of valid rodent models for antipsychotic-induced metabolic adverse effects is hampered by the fact that such effects occur in females only. Estradiol is a predominant f...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrede, Silje, González-García, Ismael, Martins, Luís, Berge, Rolf Kristian, Nogueiras, Ruben, Tena-Sempere, Manuel, Mellgren, Gunnar, Steen, Vidar Martin, López, Miguel, Fernø, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716078/
https://www.ncbi.nlm.nih.gov/pubmed/29020342
http://dx.doi.org/10.1093/ijnp/pyx073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716078/
https://www.ncbi.nlm.nih.gov/pubmed/29020342
http://dx.doi.org/10.1093/ijnp/pyx073

Ejemplares similares